Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 3 Interventional

Pivotal 2 Study of RGX-314 Gene Therapy in Participants With nAMD

ClinicalTrials.gov ID: NCT05407636

Public ClinicalTrials.gov record NCT05407636. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 17, 2026, 6:58 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Partially Masked, Controlled, Phase 3 Clinical Study to Evaluate the Efficacy and Safety of RGX-314 Gene Therapy in Participants With nAMD

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

ABBV-RGX-314 (also known as RGX-314 and surabgene lomparvovec (sura-vec)) is being developed as a novel one-time gene therapy for the treatment of neovascular (wet) age-related macular degeneration (wet AMD). Wet AMD is characterized by loss of vision due to new, leaky blood vessel formation in the retina. Wet AMD is a significant cause of vision loss in the United States, Europe and Japan, with up to 2 million people living with wet AMD in these geographies alone. Current anti-vascular endothelial growth factor (VEGF) therapies have significantly changed the landscape for treatment of wet AMD, becoming the standard of care due to their ability to prevent progression of vision loss in the majority of patients. These therapies, however, require life-long intraocular injections, typically repeated every four to 12 weeks in frequency, to maintain efficacy. Due to the burden of treatment, patients often experience a decline in vision with reduced frequency of treatment over time. ABBV-RGX-314 is being developed as a potential one-time treatment for wet AMD.

Study identification

NCT ID
NCT05407636
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
AbbVie
Industry
Enrollment
735 participants

Conditions and interventions

Eligibility (public fields only)

Age range
50 Years to 89 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 13, 2022 (Actual)
Primary completion
Oct 2026 (Estimated)
Completion
Nov 2027 (Estimated)
Last update posted
Aug 3, 2026

2022 – 2027

United States locations

U.S. sites
107
U.S. states
33
U.S. cities
97
Facility City State ZIP Site status
Barnet Dulaney Eye Center-Phoenix /ID# 256340 Phoenix Arizona 85016 —
Retinal Research Institute /ID# 256238 Phoenix Arizona 85053 —
Retina Macula Institute of Arizona /ID# 271026 Scottsdale Arizona 85255-4134 —
California Retina Consultants - Bakersfield /ID# 256240 Bakersfield California 93309-1677 —
Retina Vitreous Assoc Med Grp /ID# 256246 Beverly Hills California 90211 —
Retinal Diagnostic Center /ID# 256262 Campbell California 95008 —
The Retina Partners - Encino /ID# 259660 Encino California 91436 —
Retina Consultants of Orange County /ID# 256267 Fullerton California 92835 —
Jacobs Retina Center at UCSD/ID# 256320 La Jolla California 92093 —
California Retina Consultants - Oxnard - North Ventura Road /ID# 262883 Oxnard California 93036 —
Byers Eye Institute Stanford /ID# 262853 Palo Alto California 94303 —
Retina Consultants of San Diego /ID# 256258 Poway California 92064-2530 —
Kaiser Permanente - Riverside Medical Center /ID# 262413 Riverside California 92505 —
UC Davis Health Eye Center Sacramento California 95817 —
Retinal Consultants Medical Group, Inc. - Greenback /ID# 256353 Sacramento California 95841 —
Orange County Retina Medical Group /ID# 256286 Santa Ana California 92705 —
Macula Retina Vitreous Center - Torrance /ID# 270247 Torrance California 90503 —
Bay Area Retina Associates - Walnut Creek - Lennon Lane /ID# 268513 Walnut Creek California 94598 —
Retina Consultants of Southern Colorado /ID# 256285 Colorado Springs Colorado 80909 —
Southwest Retina Research Center /ID# 256261 Durango Colorado 81303 —
Colorado Retina Associates /ID# 256378 Lakewood Colorado 80228 —
Advanced Vision Research Institute /ID# 256380 Longmont Colorado 80503 —
Retina Consultants, P.C. /ID# 273610 Manchester Connecticut 06042-3556 —
Rand Eye Institute /ID# 256337 Deerfield Beach Florida 33064 —
National Ophthalmic Research Institute /ID# 256344 Fort Myers Florida 33912-7125 —
Vitreoretinal Associates, P.A. /ID# 256266 Gainesville Florida 32607 —
Florida Retina Consultants /ID# 256321 Lakeland Florida 33805 —
Florida Retina Institute - Orlando /ID# 256373 Orlando Florida 32806-1101 —
Retina Specialty Institute /ID# 256268 Pensacola Florida 32503 —
Fort Lauderdale Eye Institute /ID# 266011 Plantation Florida 33324 —
Retina Vitreous Associates of Florida - St. Petersburg /ID# 256279 St. Petersburg Florida 33711-1141 —
Center for Retina and Macular Disease /ID# 256335 Winter Haven Florida 33880 —
Georgia Retina - Marietta /ID# 256264 Marietta Georgia 30060 —
Retina Consultants of Hawaii /ID# 256278 ‘Aiea Hawaii 96701 —
Northwestern Memorial Hospital - Department of Ophthalmology /ID# 256379 Chicago Illinois 60611-2987 —
University Retina and Macula Associates /ID# 256288 Lemont Illinois 60439 —
University Retina and Macula Associates /ID# 256287 Oak Forest Illinois 60452 —
Illinois Retina Associates - Oak Park /ID# 256375 Oak Park Illinois 60304 —
Springfield Clinic - First /ID# 256371 Springfield Illinois 62702 —
Retina Partners Midwest, PC /ID# 256277 Indianapolis Indiana 46290 —
John-Kenyon American Eye Institute -New Albany /ID# 256283 New Albany Indiana 47150 —
Wolfe Eye Clinic - West Des Moines /ID# 256314 West Des Moines Iowa 50266 —
Retina Associates - Lenexa /ID# 258296 Lenexa Kansas 66215 —
Maine Eye Center - Marginal Way Campus /ID# 256391 Portland Maine 04101 —
Retina Specialists /ID# 256392 Baltimore Maryland 21204 —
Johns Hopkins Hospital /ID# 256236 Baltimore Maryland 21287 —
Mid Atlantic Retina Specialists - Hagerstown /ID# 256310 Hagerstown Maryland 21740-5965 —
MA Eye & Ear Infirmary /ID# 262430 Boston Massachusetts 02114 —
Ophthalmic Consultants of Boston /ID# 256233 Boston Massachusetts 02114 —
Vitreo Retinal Associates - Worcester /ID# 266008 Worcester Massachusetts 01605 —
Retina Associates of Michigan /ID# 256393 Grand Blanc Michigan 48439 —
Associated Retinal Consultants /ID# 256269 Royal Oak Michigan 48073 —
VitreoRetinal Surgery PLLC DBA Retina Consultants of Minnesota /ID# 256272 Edina Minnesota 55435 —
Mayo Clinic - Rochester /ID# 258295 Rochester Minnesota 55905-0001 —
Mississippi Retina Associates /ID# 270934 Madison Mississippi 39110-2028 —
Mid America Surgery Center /ID# 258993 Chesterfield Missouri 63017 —
University of Missouri Hospital /ID# 262474 Columbia Missouri 65212 —
Washington University School of Medicine - St. Louis /ID# 256383 St Louis Missouri 63108 —
Sierra Eye Associates /ID# 256239 Reno Nevada 89502 —
Envision Ocular, LLC /ID# 256367 Bloomfield New Jersey 07003 —
Monmouth Retina Consultants /ID# 275895 Little Silver New Jersey 07739 —
Columbia University of New York - Edward S. Harkness Eye Institute /ID# 256342 New York New York 10032 —
Retina Associates of Western New York /ID# 256374 Rochester New York 14620 —
Asheville Eye Associates- Retina Division /ID# 256355 Asheville North Carolina 28803 —
Duke University Medical Center /ID# 256245 Durham North Carolina 27710 —
Graystone Eye /ID# 256424 Hickory North Carolina 28602 —
Cincinnati Eye Institute /ID# 256247 Cincinnati Ohio 45242-5664 —
Retina Associates of Cleveland-Middleburg Heights /ID# 256280 Cleveland Ohio 44130 —
Cleveland Clinic - Cleveland /ID# 256282 Cleveland Ohio 44195 —
Ohio State University /ID# 256275 Columbus Ohio 43210 —
Midwest Retina /ID# 276644 Dublin Ohio 43016 —
Retina Vitreous Center, Research /ID# 256284 Edmond Oklahoma 73013 —
University of Pennsylvania /ID# 258995 Philadelphia Pennsylvania 19104-5502 —
Mid Atlantic Retina /ID# 256232 Philadelphia Pennsylvania 19107 —
University of Pittsburgh Medical Center /ID# 258994 Pittsburgh Pennsylvania 15213 —
Charleston Neuroscience Institute - Beaufort /ID# 256385 Beaufort South Carolina 29902-6216 —
Charleston Neurosciences Institute /ID# 256351 Charleston South Carolina 29414-5896 —
Palmetto Retina Center-Florence /ID# 256244 Florence South Carolina 29501 —
Charleston Neurosciences Institute /ID# 256336 Ladson South Carolina 29414-5896 —
Black Hills Regional Eye Institute /ID# 262872 Rapid City South Dakota 57701 —
Southeastern Retina Associates - Chattanooga /ID# 258992 Chattanooga Tennessee 37421 —
Charles Retina Institute /ID# 256237 Germantown Tennessee 38138 —
Southeastern Retina Associates - Johnson City /ID# 256396 Johnson City Tennessee 37604 —
Tennessee Retina - Nashville /ID# 256388 Nashville Tennessee 37203-1513 —
Vanderbilt University Medical Center /ID# 256372 Nashville Tennessee 37232-0011 —
Retina Research Institute of Texas /ID# 256263 Abilene Texas 79606-1224 —
Austin Research Center for Retina /ID# 256265 Austin Texas 78705 —
Austin Clinical Research, LLC /ID# 256274 Austin Texas 78750-2298 —
Retina Consultants of Texas - Bellaire /ID# 256377 Bellaire Texas 77401 —
Star Retina - Burleson /ID# 256376 Burleson Texas 76028 —
Texas Retina Associates /ID# 256259 Dallas Texas 75231 —
Texas Retina Associates - Fort Worth /ID# 256326 Fort Worth Texas 76104 —
Austin Retina Associates - Round Rock /ID# 256387 Round Rock Texas 78681 —
Retina Consultants of Texas/ID# 259661 San Antonio Texas 78240-1655 —
Retina Associates of South Texas San Antonio Texas 78240 —
Retina Consultants of Texas /ID# 256382 San Antonio Texas 78251 —
Retina Center Of Texas (Rct) - Southlake /ID# 256281 Southlake Texas 76092 —
Rocky Mountain Retina Consultants /ID# 256369 Murray Utah 84107 —
Retina Associates of Utah /ID# 256276 Salt Lake City Utah 84107 —
Piedmont Eye Center /ID# 256386 Lynchburg Virginia 24502 —
Wagner Kapoor Research Institute - Norfolk /ID# 256260 Norfolk Virginia 23502 —
Retina Institute of Virginia /ID# 256394 Richmond Virginia 23235 —
Vistar Eye Center /ID# 271024 Roanoke Virginia 24019 —
Pacific Northwest Retina /ID# 258999 Bellevue Washington 98004 —
Retina Center NW, PLLC /ID# 256395 Silverdale Washington 98383 —
Spokane Eye Clinic /ID# 256338 Spokane Washington 99204 —
Gundersen Health System - La Crosse Medical Center /ID# 276012 La Crosse Wisconsin 54601 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 74 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05407636, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 3, 2026 · Synced Oct 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT05407636 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →